Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Research Article

Renal Stem Cells, Renal Resistive Index, and Neutrophil Gelatinase Associated Lipocalin Changes After Revascularization in Patients With Renovascular Hypertension and Ischemic Nephropathy

Author(s): Rosario Cianci, Mariadelina Simeoni*, Antonietta Gigante, Adolfo Marco Perrotta, Sonia Ronchey, Nicola Mangialardi, Annalisa Schioppa, Oriana De Marco, Eleonora Cianci, Cristiana Barbati, Silvia Lai and Claudio Ferri

Volume 29, Issue 2, 2023

Published on: 06 January, 2023

Page: [133 - 138] Pages: 6

DOI: 10.2174/1381612829666221213104945

Price: $65

Abstract

Background: Percutaneous transluminal renal angioplasty (PTRA) with or without stenting is the gold standard therapy in patients with atherosclerotic renal artery stenosis (aRAS). However, therapeutic success depends on the correct timing of revascularization and the reversibility of the renal damage.

Materials and Methods: We report a case series of patients treated with PTRA for renovascular hypertension and ischemic nephropathy. We measured bilateral renal resistive index (RRI), circulating renal stem cells (RSC), and Neutrophil Gelatinase Associated Lipocalin (NGAL) at baseline and after PTRA at different time points to understand their changes in post-revascularization.

Results: At baseline, the studied patients (n = 5) had different RSC levels. After PTRAs, all patients showed an improvement in blood pressure, while renal function varied differently within the studied subjects. RRI > 0.75 at baseline and the absence of NGAL decrease after PTRAs were associated with post-PTRA renal function worsening, despite an increase of RSC in all patients.

Conclusion: Although limited to a few patients, our observation allowed the exploration of the behaviour of the studied parameters in different degrees of renal ischemia. This revealed different disease models suggesting the importance of further investigations in larger and homogeneous cohorts to confirm that a greater basal RSC percentage, low RRI values before PTRA, and a post-revascularization NGAL reduction could be related to better renal outcomes in aRAS patients.

[1]
Textor SC, Lerman LO. The role of hypoxia in ischemic chronic kidney disease. Semin Nephrol 2019; 39(6): 589-98.
[http://dx.doi.org/10.1016/j.semnephrol.2019.10.008] [PMID: 31836041]
[2]
D’Onofrio G, Simeoni M, Rizza P, et al. Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients. Ren Fail 2017; 39(1): 45-53.
[http://dx.doi.org/10.1080/0886022X.2016.1244077] [PMID: 27778533]
[3]
Simeoni M, Borrelli S, Garofalo C, et al. Atherosclerotic-nephropathy: An updated narrative review. J Nephrol 2021; 34(1): 125-36.
[http://dx.doi.org/10.1007/s40620-020-00733-0] [PMID: 32270411]
[4]
Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens 2010; 23(11): 1159-69.
[http://dx.doi.org/10.1038/ajh.2010.174] [PMID: 20864945]
[5]
Cianci R, Simeoni M, Zingaretti V, et al. Resistant hypertension: drug-eluting balloon for revascularization of bilateral renal fibromuscular dysplasia. QJM 2021; 114(2): 119-21.
[http://dx.doi.org/10.1093/qjmed/hcaa295] [PMID: 33098416]
[6]
Cianci R, Perrotta AM, Gigante A, et al. Ischemic nephropathy: The role of the renal artery stenosis revascularization on renal stem cells. Medicina 2021; 57(9): 944.
[http://dx.doi.org/10.3390/medicina57090944]
[7]
Dekel B, Zangi L, Shezen E, et al. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol 2006; 17(12): 3300-14.
[http://dx.doi.org/10.1681/ASN.2005020195] [PMID: 17093069]
[8]
Bussolati B, Bruno S, Grange C, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005; 166(2): 545-55.
[http://dx.doi.org/10.1016/S0002-9440(10)62276-6] [PMID: 15681837]
[9]
Cao J, Lu X, Gao F, Zhang X, Xia X, Sun H. Assessment of neutrophil gelatinase-associated lipocalin as an early biomarker for canine renal ischemia-reperfusion injury. Ann Transl Med 2020; 8(22): 1491.
[http://dx.doi.org/10.21037/atm-20-6314] [PMID: 33313236]
[10]
Strazzulla A, Coppolino G, Barreca GS, et al. Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals. Clin Mol Hepatol 2018; 24(2): 151-62.
[http://dx.doi.org/10.3350/cmh.2017.0059] [PMID: 29684978]
[11]
Ko GJ, Grigoryev DN, Linfert D, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 2010; 298(6): F1472-83.
[http://dx.doi.org/10.1152/ajprenal.00619.2009] [PMID: 20181666]
[12]
Zhang Y, Qiao S, Wang R, Guo X. NGAL attenuates renal ischemia/reperfusion injury through autophagy activation and apoptosis inhibition in rats. Chem Biol Interact 2018; 289: 40-6.
[http://dx.doi.org/10.1016/j.cbi.2018.04.018] [PMID: 29704511]
[13]
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7.
[http://dx.doi.org/10.1126/science.284.5411.143] [PMID: 10102814]
[14]
Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol 2006; 17(9): 2443-56.
[http://dx.doi.org/10.1681/ASN.2006010089] [PMID: 16885410]
[15]
Gupta S, Verfaillie C, Chmielewski D, et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol 2006; 17(11): 3028-40.
[http://dx.doi.org/10.1681/ASN.2006030275] [PMID: 16988061]
[16]
Cianci R, Martina P, Cianci M, et al. Ischemic nephropathy: Proteinuria and renal resistance index could suggest if revascularization is recommended. Ren Fail 2010; 32(10): 1167-71.
[http://dx.doi.org/10.3109/0886022X.2010.516856] [PMID: 20954976]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy